Page last updated: 2024-08-26
tretazicar and Emesis
tretazicar has been researched along with Emesis in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Anderson, D; Baddeley, J; Chung-Faye, G; Clark, J; Downes, M; Ferry, D; Harris, PA; Hussain, S; Kerr, DJ; Murray, PI; Palmer, D; Searle, P; Seymour, L | 1 |
Trials
1 trial(s) available for tretazicar and Emesis
Article | Year |
---|---|
Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.
Topics: Abdominal Pain; Adenoviridae; Adult; Aged; Anorexia; Antineoplastic Agents; Aziridines; Diarrhea; Dose-Response Relationship, Drug; Fatigue; Female; Gastrointestinal Neoplasms; Genetic Vectors; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Middle Aged; Nausea; Nitroreductases; Prodrugs; Treatment Outcome; Vomiting | 2001 |